Mature Clinical Labeling Models and Language Excellence

Reduce rework and approval latency to enable faster, scalable, and more predictable study start-up.

Navigating Intensifying Pressure in Clinical Labeling for Global Studies?

Help is on the way.

Regulatory demands, evolving requirements, and the constant need for accuracy and speed are creating unprecedented challenges in clinical trial labeling.

Initiatives such as Accelerating Clinical Trials in the European Union (ACT EU) are pushing sponsors, Contract Development and Manufacturing Organizations (CDMOs), and clinical supply organizations to accelerate trial start-up and expand multinational studies. However, fragmented workflows and immature operating models often create bottlenecks that hinder scalability, slow site activation readiness, and increase the risk of errors and rework.

In this webinar, we’ll share practical approaches to mature clinical labeling operating models and “language excellence” as an operational capability — standardization, consistency, and validated reuse that support compliant, scalable execution from Master English Label Text (MELT) to Country Label Text (CLT).

Join our webinar to learn how mature clinical labeling models and effective language strategies support compliance and scalability in global studies, thereby promoting timely access to innovative medicines for patients.

Webinar details:

Wednesday, March 18, 2026
10:00 a.m. ET / 16:00 CET

You’ll walk away with:

Strategies to minimize rework loops and approval delays
Operating model patterns that improve compliance, scalability, and predictability
Guidance for optimizing the transition from MELT to CLT
Best practices for achieving high-quality labeling outcomes across markets

As a special bonus, all registrants will receive access to our comprehensive whitepaper on clinical labeling.

Plus, our panel, featuring Lionbridge clinical labeling and language experts Mayowa Ojeyomi and Pia Windelov, and our external regulatory and labeling expert Martin Koenig, will set aside time to answer your questions.

The session will be available in six languages via AI-generated live captions.

Register Now

Please enter business email.

Please let us know if you have any questions or topics you'd like covered:

To find out how we process your personal information, consult our Lionbridge Privacy Policy.

Meet the Featured Speakers

Martin Koenig

Pharma Consultant

For almost 35 years, Martin has served as a global subject-matter expert and people manager at Sandoz (then Novartis), in R&D, spanning multiple therapeutic areas and line functions. He has extensive experience in global Regulatory Affairs for pharmaceuticals, including small molecules, peptides, and monoclonal antibodies. He also worked on the development of a Companion Diagnostic. Educated in pharmaceutical sciences (Pharmacist), Martin earned a PhD in Medicinal Chemistry from the University of Freiburg / Breisgau, and an EUCOR Diploma in Pharmaceutical Medicine from the Universities of Basel/Freiburg/Strasbourg. Throughout his career, he has worked in an intercultural context, frequently visiting affiliates and regulatory agencies in Europe, the United States, Canada, Asia Pacific, and South America. As a regulatory affairs project executive, Martin bridged technical, preclinical, and clinical development data with regulatory requirements on a global scale, with the goal of creating best-in-class regulatory documents.

Mayowa Ojeyomi

Global Program Director, Clinical and Regulatory Labeling, Lionbridge

Mayowa leads Lionbridge’s Clinical and Regulatory labeling services, partnering with pharmaceutical sponsors, clinical supply teams, and Regulatory Affairs teams to deliver compliant, submission-ready labeling through expert-led execution and process innovation. With a focus on operational governance across complex global programs, Mayowa reduces late-stage rework and accelerates timelines through standardization, automation, and AI-enabled workflows — helping teams improve quality, consistency, and speed for the benefit of trial participants and patients.

Pia Windelov

VP, Life Sciences Strategy and Product Marketing, Lionbridge

Pia has served as a global subject matter expert at Lionbridge Life Sciences for almost a decade. Before that, she worked for nearly two decades in R&D and across multiple therapeutic areas in the pharmaceutical and MedTech industries. She brings extensive experience in clinical and medical device development, as well as Companion Diagnostics. Educated in linguistics, intercultural communication, and project management, Pia bridges Life Sciences and linguistics to deliver successful, purpose-driven language outcomes that benefit patients, users, healthcare professionals, and the public.

WHAT WE DO

Industries

RESOURCES

WHO WE ARE